Inspire Medical Company Insiders

INSP Stock  USD 52.07  -0.09  -0.17%   
Slightly above 86 percent of Inspire Medical's insiders are actively selling. The analysis of the overall insider sentiment regarding Inspire Medical Systems suggests that quite a large number of insiders are panicking. Inspire Medical employs about 1.3 K people.
Timothy Herbert  CEO
President, Chief Executive Officer, Director
Marilyn Nelson  Chairman
Independent Chairman of the Board
Insider Sentiment
Mostly Selling
 
Selling
 
Buying

Latest Trades

2026-01-09John RondoniDisposed 109 @ 100View
2025-11-28Shawn MccormickDisposed 2000 @ 127.48View
2025-08-29Richard BuchholzDisposed 11000 @ 93.39View
2025-08-08Myriam CuretDisposed 4 @ 77.28View
2025-05-08Myriam CuretDisposed 2 @ 153.22View
2025-05-02Shawn MccormickDisposed 360 @ 160View
2025-04-07Myriam CuretAcquired 1 @ 148.26View
Following insider trading sentiment in Inspire Medical can help investors add context around confidence, timing, and operating risk while the public narrative is still evolving. This data should be handled carefully because insiders are required to disclose trades publicly and the motives behind a trade are not always purely directional.

Inspire Medical's Workforce Through the Years

Historical employee data for Inspire Medical can give investors another way to assess whether the business is scaling, restructuring, or stabilizing across different operating conditions. Current projections suggest a workforce around slightly above 1,330 employees by April 2026, which should be reviewed alongside revenue and margin trends.
Macro event markers
 
Covid
 
Interest Hikes

Management Team Effectiveness

The company has return on total asset (ROA) of 3.71 % suggesting that asset deployment is earning returns that cover operational costs. This is neither notably high nor low for the sector. Similarly, it shows a return on stockholder's equity (ROE) of 19.77 %, suggesting that shareholder investment generated $19.77 per $100 in returns.
As of the week of March 24, Common Stock Shares Outstanding is likely to trend lower to approximately 24.8 M. In addition to that, Net Loss is likely to trend lower to approximately -42.4 M.

Stock Institutional Investors

About 98.11% of Inspire Medical Systems is held by institutions, with insiders at 1.89%. Current market capitalization is about 1.56 Billion. This helps separate index flows from active bets. Shares outstanding are near 28.6 M. Whether the institutional base is growing or shrinking quarter over quarter matters more than the current snapshot.
Shares
Braidwell Lp2025-12-31
540.9 K
Marshall Wace Asset Management Ltd2025-12-31
531.1 K
Deutsche Bank Ag2025-12-31
516.8 K
Citadel Advisors Llc2025-12-31
511.3 K
Geode Capital Management, Llc2025-12-31
491.8 K
Ubs Group Ag2025-09-30
467.7 K
Aberdeen Group Plc2025-12-31
460.9 K
Bnp Paribas Arbitrage, Sa2025-12-31
454.8 K
Morgan Stanley - Brokerage Accounts2025-09-30
450.6 K
Blackrock Inc2025-09-30
3.5 M
Vanguard Group Inc2025-12-31
M
Inspire Medical Systems smaller-cap profile at 1.56 Billion shapes market structure and potential liquidity pressure during stressed periods. The business currently sits in the Healthcare sector and the Medical Devices industry. Reading Inspire Medical Systems holder concentration alongside float turnover and volatility adds the best context for understanding how smaller-cap ownership shapes price.

Insider Trading Activities

Reviewing insider trades in Inspire Medical Systems shows whether management is acting in line with the public story on growth and strategy. Current market capitalization is about 1.56 Billion. These records work best as context, not as standalone buy-or-sell signals.

Outstanding Bonds

Corporate bonds issued by Inspire Medical Systems matter because they shape interest expense, maturity risk, and the flexibility management has during tighter credit conditions. Current market capitalization is about 1.56 Billion. Bond investors and equity investors often care about the same cash flows, but they rank the risks differently.

Corporate Filings

20th of March 2026
Other Reports
ViewVerify
9th of March 2026
Other Reports
ViewVerify
F3
24th of February 2026
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
F4
18th of February 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
17th of February 2026
An amended filing to the original Schedule 13G
ViewVerify
10K
13th of February 2026
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
8K
11th of February 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
10th of February 2026
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
The majority of Inspire Medical's outstanding shares are owned by institutional investors. Institutional investors such as pension funds, mutual funds, and asset managers typically hold large positions as part of their investment mandates, managing money on behalf of clients or beneficiaries. As a result, they are subject to reporting requirements and oversight rules - such as 13F filings and position disclosure thresholds - that do not apply to individual retail investors. Institutional investors hold approximately 98% of Inspire Medical's outstanding shares, with insiders holding 2% and 0% in the public float.
 
Shares in Circulation  
 First Issued
2017-03-31
 Previous Quarter
29.6 M
 Current Value
29.2 M
 Average Shares Outstanding
25 M
 Quarterly Volatility
6.1 M
Macro event markers
 
Covid
 
Interest Hikes

Holders Distribution

A large institutional presence around Inspire Medical Systems deserves attention because well-resourced investors can establish or unwind positions quickly enough to change the market character of the security. One practical risk is that institutions can own millions of shares, so concentrated selling can pressure the stock quickly once sentiment changes.

Market Cap and Value

Workforce Comparison

Inspire Medical Systems is rated below average for number of employees against industry peers. The total workforce of Health Care industry is currently estimated at about 66,983. Inspire Medical claims roughly 1,333 in number of employees contributing just under 2% to equities under Health Care sector.

Profit Margins

The company has Profit Margin (PM) of 16.0 %, which suggests that the company can sustain investment in growth while remaining profitable. This is in the stronger tier for the industry. Similarly, it shows Operating Margin (OM) of 17.0 %, which entails that for every 100 dollars of sales, the company generated a net operating income of $17.0.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.650.8539
Way Down
Slightly volatile

Insider Trading History

The insider trade history for Inspire Medical Systems reveals whether executives were buying or selling during key price moves. Investors focus on trades outside normal pay timelines, as those are more likely to reflect genuine conviction.
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2026-03-01
0.6667
4
6
865.00
2,385
2025-12-01
2.0
4
2
1,067
3,200
2025-09-01
0.8571
6
7
25,641
41,392
2025-06-01
2.8
14
5
14,619
6,131
2025-03-01
0.6667
20
30
116,755
76,490
2024-12-01
0.5455
6
11
9,042
151,888
2024-09-01
0.5882
10
17
43,381
60,349
2024-06-01
1.0
18
18
13,462
65,840
2024-03-01
1.5667
47
30
133,568
64,926
2023-12-01
1.5556
14
9
212,062
286,994
2023-09-01
0.6
24
40
32,136
269,542
2023-06-01
0.7941
27
34
29,332
40,736
2023-03-01
0.6
24
40
95,718
134,646
2022-12-01
0.6667
16
24
163,125
202,698
2022-09-01
8.0
8
1
10,274
6,218
2022-06-01
1.4375
23
16
42,787
111,520
2022-03-01
0.5714
20
35
188,079
418,864
2021-12-01
1.2222
11
9
20,523
58,485
2021-09-01
1.0
10
10
6,448
11,091
2021-03-01
0.68
17
25
70,439
113,354
2020-12-01
0.4722
17
36
209,965
153,125
2020-09-01
0.3208
17
53
84,334
1,082,679
2020-06-01
0.76
19
25
95,127
190,600
2020-03-01
0.3043
14
46
237,384
2,368,482
2019-12-01
0.325
13
40
167,459
408,857
2019-09-01
0.2034
12
59
77,109
723,394
2019-06-01
0.3594
23
64
338,210
806,481
2019-03-01
0.1765
9
51
39,169
3,122,720
2018-12-01
0.6818
15
22
465,108
3,692,223
2018-06-01
0.7727
68
88
19,811,609
122,858,621
2012-06-01
2.1429
15
7
258,274
256,425
2012-03-01
0.5333
8
15
151,375
346,479
2011-12-01
1.3333
4
3
300,000
5,751
2011-09-01
0.3333
2
6
29,998
68,829
2011-06-01
2.0
12
6
107,050
56,881
2011-03-01
0.5
2
4
12,750
23,770
2010-12-01
0.2174
5
23
35,000
604,519
2010-06-01
1.0
16
16
471,799
206,387
2010-03-01
0.6571
23
35
1,040,461
664,089
2009-12-01
0.5
3
6
113,333
154,642
2009-09-01
0.5
13
26
36,624
49,967
2009-06-01
7.5
15
2
879,166
9,218
2009-03-01
0.5769
15
26
1,656,622
79,964
2008-12-01
0.7188
23
32
591,373
2,530,213
2008-09-01
0.4706
8
17
24,255
43,711
2008-06-01
1.0
9
9
26,280
3,259
2008-03-01
1.0
21
21
483,496
182,711
2007-12-01
0.5938
19
32
507,958
396,672
2007-09-01
1.5
9
6
565,893
4,921
2006-06-01
0.3
6
20
72,000
84,000
2006-03-01
1.0
3
3
590,000
80,000
2005-12-01
0.1667
4
24
260,000
520,000
2005-06-01
1.6667
5
3
38,000
16,000
2005-03-01
0.1875
3
16
53,000
126,000
2004-12-01
0.25
2
8
69,979
139,958
2004-06-01
2.3333
7
3
111,000
52,000
2004-03-01
1.0
3
3
33,006
62,718

Notable Stakeholders

Stakeholder analysis for Inspire Medical is useful because companies often face trade-offs among groups that want very different outcomes from the same business. Inspire Medical's stakeholders can support or challenge the entity's direction, which is why tracking them can add context around price-sensitive developments.
Timothy HerbertPresident, Chief Executive Officer, DirectorProfile
Marilyn NelsonIndependent Chairman of the BoardProfile
Steven JandrichChief Compliance Officer, Vice President of Human ResourcesProfile
Randall BanSenior Vice President Global Sales and MarketingProfile
Matthew OsbergExecutive CFOProfile
Richard BuchholzChief Financial OfficerProfile
Philip EbelingChief Operating OfficerProfile
Georgia GarinoisMelenikiotouIndependent DirectorProfile
Megan CPADirector ReportingProfile
Shawn McCormickIndependent DirectorProfile
Jerry GriffinIndependent DirectorProfile
Casey TanseyIndependent DirectorProfile
Gary EllisIndependent DirectorProfile
Dana MeadIndependent DirectorProfile
Shelley BroaderIndependent DirectorProfile
Joe SanderSVP SalesProfile
Bryan JDGeneral VPProfile
Martin AbramsVice ExperienceProfile
John RondoniChief OfficerProfile
Jason KellyChief OfficerProfile
Ivan LubogoSenior SalesProfile
Bryan PhillipsSenior Vice President Chief Compliance Officer, General Counsel, Company SecretaryProfile
Melissa MannChief OfficerProfile
Ezgi YagciVice RelationsProfile
Andreas HenkeExecutive EuropeProfile
Kathy SherwoodSenior AccessProfile
Carlton WeatherbyChief OfficerProfile
Georgia MelenikiotouIndependent DirectorProfile
MD FAAOSChief OfficerProfile

Management Information & Data Sources

Inspire Medical is a small-cap company in Health Care Technology, Health Care Equipment & Services, Health Care. Executive review focuses on insiders, senior management, and employee signals. Organizational trends can support analysis of efficiency, oversight, and decision-making consistency. CEO is Timothy Herbert with 1,333 employees and 29 reported executives.

The analytics block for Inspire Medical Systems relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Sell-side coverage, where present, supplements the data shown. Timing can vary by data vendor. Insider and management fields are mapped from published filings and company disclosures.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on March 8th, 2026

Workforce Efficiency and Productivity

Workforce efficiency at Inspire Medical Systems can help investors judge how effectively labor resources are being converted into revenue and profit over time. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.

Inspire Medical Manpower Efficiency

Return on Inspire Medical Manpower

Revenue Per Employee684.2K
Revenue Per Executive31.4M
Net Income Per Employee109.1K
Net Income Per Executive5M
Working Capital Per Employee365.8K
Working Capital Per Executive16.8M

Additional Tools for Inspire Stock Analysis

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume